Related Experiment Video
Updated: Jun 4, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Hypogonadism in DM1 and its relationship to erectile dysfunction
Giovanni Antonini1, Alessandro Clemenzi, Elisabetta Bucci
1Department of Neurology, II School of Medicine, University of Rome "Sapienza", c/o Ospedale Sant'Andrea, Via Grottarossa 1015, 00189 Rome, Italy. giovanni.antonini@uniroma1.it
Journal of Neurology
|February 24, 2011
Summary
Hypogonadism, characterized by hormonal imbalances like low testosterone, is common in Myotonic dystrophy type 1 (DM1) patients. This hormonal dysfunction significantly increases the risk of erectile dysfunction (ED) in individuals with DM1.
Area of Science:
- Endocrinology
- Neurology
- Genetics
Background:
- Myotonic dystrophy type 1 (DM1) presents with premature aging and multi-organ dysfunction, including endocrine system involvement.
- Erectile dysfunction (ED) is a frequent but understudied complaint in DM1 patients.
- Hypogonadism is a known contributor to ED in the general population and is observed in DM1.
Purpose of the Study:
- To investigate the association between hypogonadism and ED in DM1 patients.
- To analyze the relationship between sexual hormone profiles and erectile function in DM1.
Main Methods:
- A case-control study design was employed.
- Sexual hormone profiles (FSH, LH, testosterone, prolactin) were measured.
- Erectile function was assessed using the International Index of Erectile Function (IIEF) questionnaire.
Main Results:
- DM1 patients exhibited significantly higher gonadotropin (FSH, LH) levels and lower testosterone (T) levels compared to controls.
- 18 out of 30 DM1 patients showed hormonal evidence of hypogonadism, primarily tubular failure (elevated FSH).
- Hypogonadism with interstitial failure correlated with larger CTG repeat expansions, longer disease duration, higher disease severity, and lower IIEF scores.
- Impotence was significantly more prevalent in hypogonadal DM1 patients with interstitial failure (13/14) versus eugonadal patients (5/12).
Conclusions:
- Hypogonadism, particularly with interstitial failure, is strongly linked to erectile dysfunction in Myotonic dystrophy type 1.
- Hormonal evaluation and management of hypogonadism may be crucial for addressing ED in DM1 patients.
- The severity of DM1, indicated by CTG expansion and disease duration, influences the development of hypogonadism and ED.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...